# MARIZYME, INC.

MARIZYME, INC. is a company headquartered in Jupiter, FL, United States.

## Company overview

- **Legal name:** MARIZYME, INC.
- **Former names in filing history:** MARIZYME INC (2018-09-12 to 2023-05-10); GBS Enterprises Inc (2010-08-30 to 2018-06-27); Swav Enterprises Ltd. (2007-10-16 to 2010-08-18)
- **Classification:** Company
- **Industry (SIC):** 3841 — Surgical & Medical Instruments & Apparatus
- **Headquarters:** Jupiter, FL, United States
- **Incorporated in:** NV
- **Fiscal year end:** December 31
- **SEC CIK:** 0001413754

## About

MARIZYME, INC. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001413754, and its reported industry is Surgical & Medical Instruments & Apparatus. In 10-K filed on 2024-05-13, it reported annual revenue of USD 645,810; net income of USD -65,346,916; total assets of USD 22,015,075 for the fiscal period ended 2023-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2023 (period ended 2023-12-31)

- **Revenue:** $645,810 (USD 645,810)
- **Net income:** -$65.3M (USD -65,346,916)
- **Total assets:** $22.0M (USD 22,015,075)
- **Operating cash flow:** -$4.7M (USD -4,684,835)
- **Later filings:** Net income: shown as originally filed; later filings report different values for the same periods.

### FY2022 (period ended 2022-12-31)

- **Revenue:** $233,485 (USD 233,485)
- **Net income:** -$38.2M (USD -38,165,870)
- **Total assets:** $38.7M (USD 38,687,638)
- **Cash and equivalents:** $510,865 (USD 510,865)
- **Operating cash flow:** -$10.9M (USD -10,852,148)

### FY2021 (period ended 2021-12-31)

- **Revenue:** $210,279 (USD 210,279)
- **Net income:** -$11.0M (USD -10,997,929)
- **Total assets:** $66.0M (USD 65,999,350)
- **Cash and equivalents:** $4.1M (USD 4,072,339)
- **Operating cash flow:** -$5.8M (USD -5,787,095)

### FY2020 (period ended 2020-12-31)

- **Revenue:** $197,136 (USD 197,136)
- **Net income:** -$5.8M (USD -5,845,053)
- **Total assets:** $47.1M (USD 47,083,561)
- **Cash and equivalents:** $2.9M (USD 2,902,762)
- **Operating cash flow:** -$3.2M (USD -3,223,836)

## Recent SEC filings

- Form 8-K — filed 2026-04-17 — period 2026-04-14 — 8-K
- Form 10-Q — filed 2025-03-05 — period 2024-09-30
- Form 8-K — filed 2025-03-04 — period 2025-03-04
- Form 10-K/A — filed 2025-02-06 — period 2023-12-31
- Form 8-K — filed 2025-01-31 — period 2025-01-31
- Form 10-Q — filed 2024-08-14 — period 2024-06-30
- Form 8-K — filed 2024-07-18 — period 2024-07-12
- Form 10-Q — filed 2024-05-28 — period 2024-03-31
- Form 10-K — filed 2024-05-13 — period 2023-12-31
- Form 8-K — filed 2024-05-06 — period 2024-05-06
- Form 8-K — filed 2024-02-06 — period 2024-01-31
- Form 8-K — filed 2023-12-28 — period 2023-12-21

---

Updated: 2026-10-23T20:06:36Z

Canonical page: https://altss.com/profile/marizyme-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology